Lead With Lupus (8.2.2024)

Save

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com - leading with lupus because everyone wants to know about lupus!

Are your patients with moderate to severe RA getting the appropriate dose? Sponsored by Genentech, Inc

Save

RA Experts (Drs. Alvin Wells, Orrin Troum, Grace Wright, Aaron Broadwell) discuss dose response differences in this podcast sponsored by Genentech. Full Prescribing Information including BOXED WARNING. 

Location, Location, Location (7.26.2024)

Save

https://mcdn.podbean.com/mf/web/m8r2j4z6txhz8iku/Location_Location_Loca…

The Best Rheumatologists (7.19.2024)

Save

This week on the RheumNow Podcast, Dr. Jack Cush reviews the news and journal reports of interesting, including irAE, pollution and Psoriasis, microwave therapy, scleroderma without scleroderma that only the best rheumatologists could discern.

Pollution And Autoimmunity (7.12.2024)

Save

Pollution and Autoimmunity (7.12.2024)

Dead Words Eulogy

Save

Dr. Jack Cush reviews the terms in rheumatology that should no longer be used in the field of rheumatology. This lecture is part of the RheumNow Live 2024 meeting, being held January 27-28, 2024 in Dallas, TX (and virtually).

Future Big BiTEs (6.28.2024)

Save

Dr. Jack Cush reviews the news, journal articles and regulatory announcements from the past week on RheumNow.com

EULAR 2024 RA Topic Panel

Save

Moderated by Dr. Jack Cush and featuring Drs. Aurelie Najm, David Liew and Jonathan Kay

EULAR 2024 SLE Topic Panel

Save

Featuring Drs. Jack Cush, Yuz Yusof, and Andrea Fava

EULAR 2024 Psoriatic Arthritis Topic Panel

Save

Moderated by Dr. Jack Cush and Featuring Drs. Eric Ruderman, Antoni Chan, and Peter Nash

EULAR 2024 Rheumatology Roundup

Save

Featuring Drs. Artie Kavanaugh and Jack Cush Discussion of highlights from the EULAR 2024 Meeting in Vienna

EULAR 2024 JAK/TYK Daily Topic Podcasts

Save

Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis? Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria: OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib Giant Cell Arteritis and Polymyalgia Rheumatica Update Dr.

EULAR 2024 SpA Daily Topic Podcasts

Save

Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis? Dr.

EULAR 2024 SLE Daily Topic Podcasts

Save

Does B Cell Depletion Matter? Drs. Yuz Yusof and Ed Vital discuss abstract OP0077 at Eular 2024 in Vienna, Austria. 3 Big Lupus Themes from EULAR 2024 Dr. Janet Pope discusses three hot topics in lupus at Eular 2024 in Vienna, Austria. POS0732 OP0255 Voclosporin and Steroids in Lupus Nephritis Dr. Jack Cush reports on abstract OP0059 presented at Eular 2024 in Vienna, Austria. JAK Inhibitors for New Indications Dr.

EULAR 2024 PsA Daily Topic Podcasts

Save

Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis? Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria: OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib JAK Inhibitors for New Indications Dr.